W. S. Simonet
Molecular Biology · 2003–2010
A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 39 citations into it
- Oncology — 14 citations into it
- Orthopedics and Sports Medicine — 6 citations into it
Whom W. S. Simonet trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from W. S. Simonet's perspective
Ordered by how strongly the researchers W. S. Simonet trusts endorse each paper. Same corpus, a different order for every researcher.
- T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ (Nature)
- Therapeutic approaches to bone diseases. (Science)
- RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β (Nature)
- Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. (Developmental Cell)
- The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption (Journal of Bone and Mineral Research)
- Bone resorption by osteoclasts. (Science)
- Distinct molecular mechanism for initiating TRAF6 signalling (Nature)
- Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). (Human Molecular Genetics)
- RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. (Proceedings of the National Academy of Sciences of the United States of America)
- RANK-L and RANK: T cells, bone loss, and mammalian evolution. (Annual Review of Immunology)
Their papers
- Osteoclast differentiation and activation (2003) — 6,592 citations
- Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. (2010) — 911 citations
- Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis (2009) — 773 citations
- Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength (2008) — 956 citations